Rhythm Pharmaceuticals

Building up its rare obesity pipeline, Rhythm Pharma to raise $150M
Building up its rare obesity pipeline, Rhythm Pharma to raise $150M
Endpoints
Rhythm Pharmaceuticals
R&D
obesity
Flag link:
Successful IPO for Rhythm Pharmaceuticals: +52%
Successful IPO for Rhythm Pharmaceuticals: +52%
GoinPharma
IPOs
Rhythm Pharmaceuticals
Flag link:
Rhythm Pharma strikes a chord with oversubscribed $120M IPO
Rhythm Pharma strikes a chord with oversubscribed $120M IPO
Fierce Biotech
Rhythm Pharmaceuticals
IPOs
Flag link:
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Endpoints
Rhythm Pharmaceuticals
IPOs
obesity
rare disease
Flag link:
Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Pfizer, OrbiMed back $40M Rhythm round for rare genetic disease R&D
Fierce Biotech
Pfizer
OrbiMed
Rhythm Pharmaceuticals
Prader-Willi Syndrome
Flag link:
Two new biotech IPOs help set the stage for the fall parade
Two new biotech IPOs help set the stage for the fall parade
Fierce Biotech
IPOs
Rhythm Pharmaceuticals
Dermira
Flag link:
Rhythm Pharmaceuticals lands $11M tranche to advance its treatment of GI disorders
Rhythm Pharmaceuticals lands $11M tranche to advance its treatment of GI disorders
bizjournals
Rhythm Pharmaceuticals
gastroparesis
diabetes
obesity
Flag link:
Rise in obesity makes VCs hungry for startups
Rise in obesity makes VCs hungry for startups
Reuters
venture capital
obesity
Rhythm Pharmaceuticals
Elixir Medical
Flag link: